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Background: Losses of slaughter-weight pigs due to transport stress are both welfare and economic concerns to
pork producers. Historically, the HAL-1843 mutation in ryanodine receptor 1 was considered responsible for most of
the losses; however, DNA testing has effectively eliminated this mutation from commercial herds. We identified two
sibling barrows in the USMARC swine herd that died from apparent symptoms of a stress syndrome after transport
at 12 weeks of age. The symptoms included open-mouth breathing, skin discoloration, vocalization and loss of
mobility.
Results: We repeated the original mating along with sire-daughter matings to produce additional offspring.
At 8 weeks of age, heart rate and electrocardiographs (ECG) were monitored during isoflurane anesthesia challenge
(3% for 3 min). Four males from the original sire-dam mating and two males from a sire-daughter mating died after
one minute of anesthesia. Animals from additional litters were identified as having a stress response, sometimes
resulting in death, during regular processing and weighing. Affected animals had elevated plasma creatine
phosphokinase (CPK) levels before and immediately after isoflurane challenge and cardiac arrhythmias. A pedigree
containing 250 pigs, including 49 affected animals, was genotyped with the Illumina PorcineSNP60 Beadchip and
only one chromosomal region, SSCX at 25.1-27.7 Mb over the dystrophin gene (DMD), was significantly associated
with the syndrome. An arginine to tryptophan (R1958W) polymorphism in exon 41 of DMD was the most
significant marker associated with stress susceptibility. Immunoblots of affected heart and skeletal muscle showed a
dramatic reduction of dystrophin protein and histopathology of affected hearts indicated muscle fiber
degeneration.
Conclusions: A novel stress syndrome was characterized in pigs and the causative genetic factor most likely resides
within DMD that results in less dystrophin protein and cardiac abnormalities that can lead to death under stressful
conditions. The identification of predictive markers will allow us to determine the prevalence of this disease in
commercial swine populations. This defect also provides a unique biomedical model for human cardiomyopathy
associated with muscular dystrophy that may be superior to those available because of the similarities in anatomy
and physiology and allow advances in gene therapies for human disease.Background
Losses of market-weight pigs present economic, legal
and animal welfare issues to U.S. swine producers and
include dead, non-ambulatory, fatigued and injured pigs
[1]. Although the incidence occurs at low frequency (less
than 1%) these losses are substantial due to added labor
and disposal costs, along with loss of full-value product
and have been estimated to be over $50,000,000 per year
in the U.S. Fatigued, non-ambulatory pigs exhibit acute
stress symptoms including open-mouth breathing,* Correspondence: dan.nonneman@ars.usda.gov
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reproduction in any medium, provided the ordiscoloration (red to purple) and blotching of skin,
muscle tremors, abnormal vocalization and refusal to
move, similar to what is observed in pigs with malignant
hyperthermia due to a mutation in the ryanodine recep-
tor 1 gene (RYR1) [2]. A DNA-based test has been avail-
able since the discovery of the mutation and producers
have been able eliminate the unfavorable RYR1 allele
from their herds [3]. Over a decade ago it was found that
half of the pigs arriving dead or dying at the packing
plants carried at least one copy of the RYR1 mutation
[4]. By 2006 the number of dead and non-ambulatory
pigs that carried the RYR1 mutation was about 5% [3];Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Plasma creatine phosphokinase activity in normal
and stress-responsive pigs
Group a Normal (n = 103) b Carrier (n = 37) Affected (n = 35) c
Pre-challenge 482.42± 41.30 573.93± 89.14 1635.27 ± 148.22
Post-challenge 644.37± 68.80 469.26± 51.08 1928.46 ± 136.37
a Pre-challenge was at 7 weeks of age, post-challenge was at 8 weeks of age
after isoflurane treatment.
b Mean and standard error of plasma CPK in units/liter. Of 192 pigs that were
sampled, not all the normal animals were challenged with isoflurane
anesthesia.
c Values were not different before or after challenge; affected pigs had
significantly greater CPK activity than normal or carrier pigs (p < 0.0001).
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that time [3]. However, a high proportion of RYR1 nor-
mal pigs show a sensitivity to halothane anesthesia [5]
and are more prone to becoming non-ambulatory after
handling [6]. Pigs that are more sensitive to halothane
exposure may also have inferior pork quality [5]. These
relationships are believed to have a genetic basis; how-
ever, the specific cause has yet to be identified.
In the U.S. Meat Animal Research Center’s swine re-
search population, a novel stress syndrome was detected.
Test matings were made to characterize the syndrome’s
physiological effects and its genetic basis. This study
reports the identification of a novel porcine stress syn-
drome and mapping of the defect to dystrophin.
Results
Identification and challenge of stress susceptible pigs
The original mating that produced pigs that died after
transport was repeated. Five males were born and three
were classified as affected when they died after adminis-
tration of isoflurane anesthesia. Because isoflurane chal-
lenge seemed to elicit a stress response, this treatment
was used to test pigs from subsequent suspect litters. A
total of 242 piglets from 32 litters (21 sows and 13
boars) were challenged with isoflurane anesthesia and
we obtained at least one plasma creatine phosphokinase
(CPK) measurement for 192 pigs, before or after
anesthesia challenge. Pigs were classified as being
affected if they died during handling, transport or iso-
flurane challenge or had high CPK levels and an abnor-
mal ECG (Figure 1). Heart rates of unaffected pigs
remained steady throughout anesthesia challenge. The










Figure 1 Electrocardiograms of normal and affected littermates. Eight
challenged with 3% isoflurane anesthesia and heart rates were monitored
30 seconds after administration of anesthesia.affected pigs compared to their unaffected littermates
both before and after isoflurane challenge (p < 0.0001,
Table 1). Females that were later confirmed to be car-
riers, based on genotype and progeny testing, had CPK
levels that were not different from unaffected animals
before or after isoflurane challenge (Table 1). Isoflurane
treatment itself did not affect CPK levels. Of the forty-
nine presumed affected pigs, based on isoflurane re-
sponse, CPK levels or assessment of their ECG, only 18
died during anesthesia. These animals showed signs of
respiratory distress and a rapid decline in heart rate usu-
ally within one minute of anesthesia. Eight affected ani-
mals died a few days after challenge while being
transported.
Mapping the stress syndrome locus
To identify the genomic region associated with the stress
syndrome, the coding regions of porcine orthologs of
human malignant hyperthermia (MH) genes RYR1,
CACNA1S, CPT2 and RYR2 were sequenced for SNP




week-old normal (top) and affected (bottom) littermates pigs were
for 3 minutes. The electrocardiograms are showing traces from 20 to
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normal and affected siblings and the syndrome did not
segregate with SNP alleles in any of the human candi-
date genes. A larger pedigree of 250 pigs, including 49
affected animals was then genotyped with the Illumina
PorcineSNP60 Beadchip. Genotypes were called for
59,895 SNPs spanning the entire porcine genome and
49,006 of these could be mapped to build 9.2 (SGSC
Sscrofa9.2/susSCR2) of the pig genome. Genome-wide
association analysis was done using the case/control as-
sociation option of PLINK [7]. Only one chromosomal
region had highly significant SNP associations, six of
which were located between 25.13 and 27.72 Mb on the
X chromosome (Figure 2). When only the 28 animals
that died during transport or isoflurane challenge were
classified as affected in the analysis, a similar but less
significant association was found with the same markers
at the dystrophin locus (p < 2 x 10-11).The two most sig-
nificant SNPs on the beadchip (ALGA0099513 and
ALGA0099514) are located within intron 44 of the dys-
trophin gene (DMD). All of the affected animals were
hemizygous or homozygous for a shared haplotype.
Sequencing of the porcine dystrophin gene
The exons and flanking intron sequences of DMD were
obtained from normal and affected pigs by PCR amplifi-
cation and direct sequencing. No polymorphisms were
identified near splice sites. The cDNA from normal and
affected animals was also amplified and sequenced and
there was no evidence of alternative splicing or deletion
of exons in the affected animals. The promoter regions
P1, P2 and the muscle-specific promoter were sequencedFigure 2 Genome-wide case/control association for stress response in
plotted against the –Log10(p-value) for SNP associations on the Y-axis. The
value) of 6. The single most significant SNP associations are on the X chromand no obvious mutations were found. Forty-seven SNPs
were found in DMD by sequencing 12 members of the
affected family; of these, five non-synonymous poly-
morphisms were found in the coding region (Additional
file 2: Table S2). One SNP in particular, 85890_783, that
causes the amino acid change arginine to tryptophan at
amino acid 1958 (R1958W) in exon 41 was predicted by
PolyPhen-2 [8] (http://genetics.bwh.harvard.edu/pph2/)
to be damaging with a probability score of 0.983.
Association of dystrophin SNPs with porcine stress
syndrome
The SNPs in the dystrophin gene identified by sequen-
cing were genotyped across the same pedigree and ana-
lyzed for association. The 85890_783 SNP (R1958W)
was as highly associated with the stress response as the
two most significant SNPs on the Illumina Beadchip
(Table 2). The C allele (arginine) was found in all un-
affected animals and the T allele (tryptophan) was found
in affected and carrier females. A survey of 122 presum-
ably unaffected 2008-born barrows from 24 sires and 76
dams all carried the C allele. The founding ancestors of
this population were genotyped for the 85890_783 SNP
and five of 12 Landrace boars carried the T allele, while
all 12 of the Duroc boars carried the C allele. Of 122 of
the founding dams (Landrace-Yorkshire composite) that
were genotyped, two were homozygous and four were
heterozygous for the T allele. In a panel of 192 unrelated
boars of different breeds [9], the T allele was only found
in 5 of 43 Landrace and 3 of 29 Hampshire boars.
Linkage disequilibrium (r2) was estimated for the SNP
using Haploview 4.0 software [10] (http://www.broad.pigs. The cumulative position in the genome (Mb) on the X-axis is
Bonferroni correction for genome-wide significance is a –Log10(p-
osome.
Table 2 Associations of SNP in dystrophin with the stress response
SNP dbSNP# Basepaira A1b F_Ac F_U A2 P-value -Log(p)
84116_121 ss410758942 26546329 A 0 0.1977 G 0.000245 3.6117
84102_437 ss410758941 26635210 T 0 0.1837 C 0.001723 2.7637
85904_613 ss410758951 27322071 T 0.03509 0.1886 C 0.004925 2.3076
85890_783 ss410758971 28023949 C 0 0.7485 T 1.06E-23 22.9759
ALGA0099514 rs80929421 27689253 C 0 0.7401 T 2.19E-23 22.6605
ALGA0099513 rs80914436 27716318 C 0 0.7401 T 2.19E-23 22.6605
85896_775 ss410758960 27762149 T 0 0.1579 A 0.001687 2.7729
84024_171 ss410758936 27786935 C 0 0.1598 A 0.00143 2.8447
85894_336 ss410758939 27840323 A 0 0.4971 C 1.28E-11 10.8935
84339_200 ss410758953 27922373 G 0 0.01163 A 0.4055 0.3920
84008_345 ss410758980 27922512 A 0 0.1579 G 0.001535 2.8139
84339_333 ss410758954 27934448 A 0 0.005848 G 0.5594 0.2523
84002_411 ss410758948 27942562 C 0 0.2059 G 0.000195 3.7091
84000_82 ss410758968 28119423 G 0 0.1471 A 0.001967 2.7062
85413_679 ss410758963 28465839 C 0 0.02013 T 0.2848 0.5455
85413_571 ss410758964 28465948 A 0 0.00578 G 0.5617 0.2505
85404_372 ss410758935 28517880 - 0 0.2073 A 0.000239 3.6220
aMap position is based on SGSC Sscrofa build 9.2.
bA1 and A2 represent the different alleles.
cF_A is the frequency of allele 1 in cases and F_U is the frequency of A1 in unaffected.
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blocks based on pair-wise LD values. The calculated r2
values for SNP 85890_783 and the two most significant
SNPs on the beadchip (ALGA0099513 and
ALGA0099514) were 0.81 (Figure 3) using the entireFigure 3 Linkage disequilbrium plot of SNPs in the dystrophin gene i
the plot, as well as the relative position of SNPs in the DMD gene. The mo
ALGA0099513) are in complete LD with each other. The most significant SN
41 (shown in red above).pedigree that contained the extended stress family and
six other unrelated affected families. Including all
founder animals, 122 barrows and 192 unrelated boars
that had been genotyped for these three markers, the r2
value was 0.64 between SNP 85890_783 andn the stress family (n = 250). The exon organization is shown above
st significant SNPs on the PorcineSNP60 beadchip (ALGA0099514 and
P in the DMD gene (85890_783; marker number 8) is located in exon
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the beadchip (ALGA0099513 and ALGA0099514) were
in complete linkage disequilibrium in both populations
(Figure 3).Evaluation of cardiac and skeletal muscle for the
dystrophin defect
Histopathology of affected left ventricular cardiac tissues
showed evidence of myofibrillar degeneration and necro-
sis (Figure 4). Myocardial fibers showed loss of cross-
striation, pyknotic nuclei and associated aggregation of
lymphocytes. Immunoblots of heart and skeletal muscle
protein from 8 week-old pigs using MANDYS8, a mouse
monoclonal anti-dystrophin antibody that recognizes
residues 1431–1505 in spectrin repeat regions 10 and 11
of human dystrophin, showed a dramatic reduction
(~50%) in dystrophin protein in affected pigs compared
to normal littermates (Figure 5). Similarly, immunoblots
of heart total protein from 6 month-old pigs usingA
B
Figure 4 Histopathology of left ventricular cardiac tissue from
an affected pig. Sections from a 1 year-old affected male pig show
myofibrillar degeneration (magnification = 30X). A. Fragmentation of
myocytes, pyknotic nuclei (arrow) and loss of cross-striation.
B. Aggregation of lymphocytes and loss of myofibrils (arrow).MANDRA1, a mouse monoclonal anti-dystrophin
antibody that recognizes residues 3667–3671 in the
C-terminus of the human protein, showed a similar
reduction in the amount of protein, as well (Figure 6).
Real-time qPCR of dystrophin in 12 affected and 12 un-
affected heart tissues using primers in exons 4 and 6
showed no difference in dystrophin mRNA abundance
(1.22 ± 0.313 vs. 1.42 ± 0.34 fold, p = 0.677, respectively).
Discussion
We have identified a porcine stress syndrome that can be
induced by transport, handling or isoflurane anesthesia.
Affected animals quickly become non-ambulatory, have
difficulty breathing and rarely recover. Isoflurane
anesthesia was tested to elicit a stress response because
we thought the stress syndrome was a malignant hyper-
thermia, similar to the classic porcine stress syndrome.
Isoflurane is more readily available, less irritating to the
respiratory system and has replaced halothane as a com-
mon anesthesia for veterinary applications. Although the
response is delayed, compared to halothane, isoflurane
can also induce malignant hyperthermia in swine [11].
Using the Illumina PorcineSNP60 Beadchip we were able
to map the defect to dystrophin on the X chromosome
and show that affected animals have reduced dystrophin
protein in heart and skeletal muscle and elevated CPK
levels in blood. These animals, however, have no appar-
ent muscle impairment later in life. Dystrophin is the lar-
gest gene in the mammalian genome covering 2.4
megabases of DNA, and contains 79 exons and multiple
tissue-specific promoters and transcripts [12]. Mutations
in dystrophin cause Duchennes Muscular Dystrophy
(DMD), Becker Muscular Dystrophy (BMD) and X-
linked dilated cardiomyopathy (XLCM) in humans [12].
Most cases of DMD or BMD involve deletions/duplica-
tions, followed by nonsense mutations and/or microdele-
tions/insertions, most of which cause a frameshift or
exon skipping; missense mutations are extremely rare
[13-16]. DMD is usually caused by deletions, duplications
or nonsense mutations that disrupt or truncate the read-
ing frame, while BMD mutations usually preserve the
reading frame [13,15]. These allelic forms are generally
characterized by the severity and age of onset of the dis-
ease with DMD manifesting within the first few years of
life as a progressive weakness and wasting of muscle,
while BMD occurs in later decades and is more variable
in severity. Patients with either DMD or BMD usually de-
velop dilated cardiomyopathy independent of the degree
of skeletal muscle involvement [17] and usually have
higher than normal circulating levels of CPK [15,18].
Likewise, patients with XLCM [19,20], also have elevated
CPK, probably due to increased membrane permeability
[21], because the absence of dystrophin makes the mem-
brane more susceptible to tears under the force of
Muscle
Normal Affected Normal Affected
Heart
Normal Affected Normal Affected
Figure 5 Immunoblot for dystrophin in skeletal and cardiac muscle from 8 week-old pigs. Pellet extract from normal and affected pigs
was run in 5% SDS-PAGE and blotted with MANDYS8 monoclonal antibody which recognizes amino acids 1410–1505. Affected pigs have a
reduction in dystrophin protein.
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etal muscle involvement is frequently caused by missense
mutations in the dystrophin gene [20]. Dystrophinopa-
thies can also present with arrhythmia [22] or cardiore-
spiratory arrest after isoflurane anesthesia [23,24]. The
pathophysiological reasons for anesthesia-induced car-
diac arrest in patients with dystrophinopathies are un-
known, however it is postulated that damaged, leaky
muscle fibers (rhabdomyolysis) can lead to increased
intracellular calcium and potassium released into the





Figure 6 Immunoblot for dystrophin in cardiac muscle from
6 month-old pigs. Total protein extract from normal and affected
pigs was run in 5% SDS-PAGE and blotted with MANDRA1
monoclonal antibody which recognizes amino acids 3558–3684.
Affected pigs have about a 50% reduction in dystrophin protein.been reported that isoflurane anesthesia or stress induced
rhabdomyolosis, hyperkalemia and death in dystrophin-
deficient cats [25]. This is the only report of stress-
induced death in a dystrophic animal.
Dystrophin protein is usually absent by Western blot
in DMD patients, while BMD patients usually have a
decreased amount of normal or abnormal size protein
[26], which is similar to the phenotype seen in the
affected pigs. While it is not clear why missense muta-
tions cause a reduction in dystrophin protein [26,27] it
may be due to damage of the protein by contractile
stress.
One of the nonsynonymous SNPs, (85890_783;
ss410758971), which causes an amino acid change of ar-
ginine to tryptophan at amino acid 1958, was the most
significant marker for the stress response and could pos-
sibly be the causative mutation. The SNP is in exon 41
of dystrophin, which codes for spectrin repeat 15 of the
central coiled-coil rod domain [28]. This basic repeat re-
gion is in the second actin-binding domain of dystrophin
(ABD2) [29] and has also been shown to bind lipid [30].
Although in vitro mutation studies have not been
reported for ABD2, missense mutations in actin-binding
domain 1 (ABD1) can cause protein instability, misfold-
ing and aggregation [31,32], leading to a reduction of
expressed protein.
The variant T allele of 85890_783 (Trp) could be
tracked to some of the founding sires and dams in the
affected families. The frequency of this allele was higher
than expected, based on the rate of spontaneous deaths
of feeder-aged pigs in the population. Thus, if this is the
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extremely high. Further studies are required to deter-
mine the causal genetic variation, the penetrance of this
phenotype and if this locus accounts for losses during
transportation of market weight animals.
Conclusions
Genetic mapping indicated the causative variation for a
novel porcine stress syndrome is likely in the dystrophin
gene. In addition to muscular dystrophies, mutations in
human dystrophin can cause dilated cardiomyopathy,
rhabdomyolosis and a malignant hyperthermia-like reac-
tion in response to inhaled anesthesia, supporting the
conclusion that this locus causes the observed pheno-
types in pigs. The identification of the causative muta-
tion in these families will allow investigation of the
prevalence of this disease in commercial populations
and its pleiotropic effects.
Methods
Animals
The animals were from a multigenerational Landrace-
Duroc-Yorkshire composite population developed at the
U.S. Meat Animal Research Center (USMARC) by mat-
ing Yorkshire-Landrace composite females (n = 220) to
either Duroc or Landrace boars selected from the indus-
try (n = 12 boars of each breed). This population was fur-
ther developed by mating female descendants (n = 10/
boar) to either a Duroc or Landrace-sired boar; Duroc-
sired animals were mated to Landrace-sired animals and
vice versa. Subsequent matings were random except that
half-sib matings were avoided. The first affected animals
identified were from the 7th generation and the sire and
dam were from the 6th generation of this population. Lit-
ters were evaluated through generation 11. All animal
procedures were reviewed and approved by the U.S.
Meat Animal Research Center Animal Care and Use
Committee and procedures for handling pigs complied
with those specified in the Guide for the Care and Use
of Agricultural Animals in Agricultural Research and
Teaching [33].
Identification of stress susceptible pigs
We identified 2 barrows in the USMARC swine herd
that died after a 1 km transport to a research location at
12 weeks of age. We reproduced the original mating
along with sire-daughter matings to produce additional
offspring. To induce a reproducible stress response, pigs
were challenged with 3% isoflurane anesthesia for 3 min
at 8 weeks of age. During the course of this study, pigs
from other litters were identified from their reactions to
regular processing, weighing or transport to the sale
barn at 5–8 weeks of age. Their littermates were also
challenged with anesthesia and additional affectedanimals were identified. A stress response was usually
indicated when the pigs stopped breathing after 1–2
minutes of anesthetic, when they were slow to awaken
after anesthesia, or displayed rigidity and blotching dur-
ing handling. Matings were continued with these related
offspring to produce additional animals. This produced a
final population of 250 animals containing 49 affected
pigs for genetic analysis.
Sample collection and phenotyping
Pigs were challenged at 8 weeks of age with isoflurane
anesthesia (3% for 3 min) and body temperature, heart
rate and ECG were monitored during anesthesia. During
the 3 minute isoflurane challenge, ECG wave forms were
obtained using a 3-wiring system recorded at 100 Hz
using a 12-bit A/D. The signal was conditioned prior to
recording using both a differential amplifier and a low
pass filter to ensure proper signal. Blood was collected
one week before challenge and immediately after isoflur-
ane administration on most animals (n = 192). Blood was
drawn into Li-heparin tubes for the measurement of cre-
atine phosphokinase. Plasma creatine phosphokinase
was measured using a 2-part reagent system (Pointe Sci-
entific Inc., Canton, MI) in a SpectraMax M5 microplate
plate reader (Molecular Devices, Sunnyvale, CA).
Twenty-five μl samples were measured in duplicate and
the rate of NADH formation was monitored at 340 nm
and 37°C. Samples that were greater than 2500 U/L were
diluted in PBS and reassayed.
Mapping the stress susceptible locus
Initially, a pedigree of 58 pigs, including 15 affected ani-
mals, was genotyped with the Illumina PorcineSNP60
Beadchip containing 64,232 SNPs and for candidate gene
SNP using the Sequenom MASSARRAYW system
(Sequenom, San Diego, CA). Additional pigs were phe-
notyped as they were generated and subsequently geno-
typed. In total, 250 pigs, including 49 affected animals,
their parents and unaffected siblings, were genotyped
with the Illumina PorcineSNP60 Beadchip (Illumina, San
Diego, CA) [34]. Genotyping of additional SNPs identi-
fied in the dystrophin gene and for candidate gene SNP
was done using the Sequenom MASSARRAYW system
(Sequenom, San Diego, CA). Multiplex assays with about
30 SNP/group were designed using MASSARRAYW
Assay Design software. Amplicon lengths were approxi-
mately 100 bp. Reaction conditions were performed as
suggested by Sequenom iPLEX chemistry. Genome-wide
associations were performed using the case–control op-
tion in PLINK [7].
Sequencing
Genomic DNA was extracted from blood buffy coats or
from tails collected shortly after birth. Exons, flanking
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amplified and sequenced from twelve animals with pri-
mers (Integrated DNA Technologies, Coralville, IA)
designed using Primer 3 [35] in a Dyad DNA engine
(Bio-Rad, Hercules, CA) using 0.5 U Hot Star Taq poly-
merase (Qiagen, Valencia, CA); 1x supplied buffer;
1.5 mM MgCl2; 200 μM dNTPs; 0.8 μM each primer;
and 100 ng genomic DNA in 25 μl reactions. The
complete mRNA of the dystrophin muscle isoform was
amplified and sequenced from cDNA using overlapping
fragments and exon primers. Promoter regions were
identified using Cister [36] and the cis-element matrices
of TRANSFAC [37]. PCR reactions were treated with 0.1
U exonuclease (USB, Cleveland, OH), and prepared for
sequencing on an ABI3730 capillary sequencer (Applied
Biosystems, Foster City, CA).
Western immunoblotting of dystrophin
Left ventricular and longissimus lumborum muscle sam-
ples from at least twelve affected and twelve age-
matched unaffected pigs were frozen in liquid nitrogen
within 10 minutes of the time of death. Protein for
Western blotting was extracted as reported before [38]
with the addition of protease inhibitor cocktail (Sigma
Chemical Co., St. Louis, MO). Dystrophin protein was
detected using 15 μg protein from cardiac and skeletal
muscle run in 5% polyacrylamide gels using MANDYS8
and MANDRA1 anti-dystrophin monoclonal antibodies
(Sigma Chemical Co., St. Louis, MO) diluted 1:400, goat
anti-mouse IgG-HRP and SuperSignalW Western Blot-
ting kit (Pierce, Rockford, IL). MANDYS8 recognizes
residues 1431–1505 [39] and MANDRA1 recognizes
residues 3667–3671 [40]. Equal loading of protein in the
wells was confirmed by Coomassie Blue staining.
Quantitative RT-PCR
Total RNA was extracted from 50 mg of porcine heart
and longissimus lumborum muscle from 8-week old or
6-month old pigs by homogenization with TriZol re-
agent (Invitrogen, Carlsbad, CA) following the manufac-
turer’s protocol. The RNA pellets were resuspended in
100 μL DEPC treated water and absorbance was mea-
sured by spectrophotometry at 260 nm. Total RNA
(2 μg) was reverse transcribed using oligo dT18 primer
and M-MLV reverse transcriptase (Promega, Madison,
WI). Primers for DMD (GenBank NM_001012408.1)
and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH, GenBank AF017079) were designed for real-
time RT-PCR using Primer 3. Primers used to amplify
DMD were located in exons 4 and 6. Dystrophin forward
primer sequence (nucleotides 423 to 444) was 5′-
tgcaggtcttgcagaaaaataa -3′ and the reverse primer se-
quence was 5′- gcaatccagccatgatattctt -3′ (nucleotides
554 to 575). GAPDH forward primer sequence(nucleotides 739 to 757) was 5′-gcgtgaaccatgagaagtatga-
3′ and the reverse primer sequence (nucleotides 947 to
967) was 5′-ggtagaagcagggatgatgttc-3′. Real-time PCR
was performed using 1X iQ™ SYBRW Green Supermix
(Bio-Rad, Hercules, CA), 0.4 ng of cDNA and 0.3 μM of
each primer. The PCR reaction was performed at 95°C
for 3 min followed by 40 cycles at 95°C for 20s, 58°C for
30s, and 70°C for 1 s on a MJ PTC-200 with a Chromo-
4 detector (MJ Research, Watertown, MA). A quantity
of 0.4 ng of cDNA was in the linear range of amplifica-
tion and used for the real-time assays. The threshold
cycle (Ct) for DMD and GAPDH of each sample was
determined and used to calculate the fold difference be-
tween samples (n = 12 affected and 12 normal pigs)
using the 2-ΔΔCt method [41].Additional files
Additional files 1: Table S1. Human Malignant Hyperthermia
Candidate Gene SNPs.
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